1-2 of 2
Fabian Zanchetta-Balint
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rituximab for Preventing Delayed Hemolytic Transfusion Reaction (DHTR) in Sickle CELL Adult Patients: Outcome of Transfusion and SIDE Effects in 58 CASES

Fabian Zanchetta-Balint, France Pirenne, MD PhD, Marc Michel, Armand Mekontso-Dessap, MD PhD, Matthieu Mahevas, MD, Constance Guillaud, MD, Keyvan Razazi, MD, Elena Foïs, MD, Frédéric Galactéros, MD PhD, Pablo Bartolucci, MD PhD, Anoosha Habibi
Journal: Blood
Blood (2019) 134 (Supplement_1): 3687.
https://doi.org/10.1182/blood-2019-130874
Published: 2019
Journal Articles

Treatment of Delayed Hemolytic Transfusion Reactions in Sickle Cell Disease Patients By an Anti-C5 Antibody

Aline Floch, MD MSc, Alexandre Morel, MD, Fabian Zanchetta-Balint, Catherine Cordonnier-Jourdin, PharmD, Slimane Allali, MD, Maximilien Grall, MD, Ghislaine Ithier, MD, Benjamin Carpentier, MD, Sadaf Pakdaman, Jean-Claude Merle, MD, Radjiv Goulabchand, MD, Tackwa Khalifeh, MD, Ana Berceanu, MD, Christelle Chantalat-Auger, MD, Véronique Frémeaux-Bacchi, MD, Marc Michel, Armand Mekontso-Dessap, MD PhD, Anoosha Habibi, France Pirenne, MD PhD, Pablo Bartolucci, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2458.
https://doi.org/10.1182/blood-2019-127176
Published: 2019